Safety and efficacy of oral HD-03/ES given for six months in patients with chronic hepatitis B virus infection

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

304

HTML

1983

Figures (1-4)

141

Tables (1-4)

175

Sum=2603

Aug 14, 2007 (publication date) through Apr 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Aug 14, 2007; 13(30): 4103-4107
Published online Aug 14, 2007. doi: 10.3748/wjg.v13.i30.4103

Figure 1 Improvement in ALT normalization after treatment with HD-03/ES.

Figure 2 Improvement in HBsAg after treatment with HD-03/ES. ^bP < 0.001 vs d 0.

Figure 3 Improvement in HBeAg after treatment with HD-03/ES. ^aP < 0.05 vs d 0.

Figure 4 Improvement in HBV DNA after treatment with HD-03/ES. ^aP < 0.05 vs d 0

Citation: Rajkumar J, Sekar M, Mitra S. Safety and efficacy of oral HD-03/ES given for six months in patients with chronic hepatitis B virus infection. World J Gastroenterol 2007; 13(30): 4103-4107
URL: https://www.wjgnet.com/1007-9327/full/v13/i30/4103.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i30.4103